Literature DB >> 3926948

A Salmonella typhimurium strain defective in uracil catabolism and beta-alanine synthesis.

T P West, T W Traut, M S Shanley, G A O'Donovan.   

Abstract

A selection procedure for uracil catabolism mutant strains involving indicator dye plates was developed. Using this method, a strain defective in uracil catabolism has been isolated in Salmonella typhimurium that was temperature-sensitive at 42 degrees C where it required low concentrations of N-carbamoyl-beta-alanine, beta-alanine or pantothenic acid for growth. An extract of the mutant strain degraded uracil at 37 degrees C at a significantly diminished rate compared to that observed for the wild-type strain under the same growth conditions. The conversion of dihydrouracil to N-carbamoyl-beta-alanine was blocked at all temperatures examined in the mutant strain. By means of genetic analysis, the mutant strain was determined to be defective at two genetic loci. Transduction studies with bacteriophage P22 indicated that the panD gene is mutated in this strain, accounting for its beta-alanine requirement. Episomal transfers between Escherichia coli and the mutant strain provided evidence that the defect in uracil catabolism was located in another region of the S. typhimurium chromosome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926948     DOI: 10.1099/00221287-131-5-1083

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  3 in total

Review 1.  Linkage map of Salmonella typhimurium, edition VII.

Authors:  K E Sanderson; J R Roth
Journal:  Microbiol Rev       Date:  1988-12

2.  Pyrimidine base and ribonucleoside utilization by the Pseudomonas alcaligenes group.

Authors:  T P West
Journal:  Antonie Van Leeuwenhoek       Date:  1991-05       Impact factor: 2.271

3.  Pathways of pyrimidine salvage in Pseudomonas and former Pseudomonas: detection of recycling enzymes using high-performance liquid chromatography.

Authors:  Debrah A Beck; Gerard A O'Donovan
Journal:  Curr Microbiol       Date:  2007-10-26       Impact factor: 2.188

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.